TPP1 and neuronal ceroid lipofuscinosis: We did not have any clinical information for three patients with five variants (homozygous or compound heterozygous, one known pathogenic and four novel variants of unknown significance) in CLN2, CLN6, and CLN8 and did not include them into our list of patients with molecular genetic confirmation of NCL (Table S2).